Educational Opportunities to Improve HER2 Testing and Use of Newer Therapies for HER2-Positive MBC Among Community Healthcare Professionals

This poster, presented at the 2022 San Antonio Breast Cancer Symposium (SABCS), illustrates challenges among oncology HCPs in optimally incorporating recommendations for the use of novel HER2-targeted therapies in the care of patients with HER2+ metastatic breast cancer.


Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings